We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+24.97%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$111B
AUM Growth
+$14.9B
Cap. Flow
-$1.95B
Cap. Flow %
-1.76%
Top 10 Hldgs %
40.37%
Holding
493
New
5
Increased
168
Reduced
169
Closed
39

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$710M
2
IOT icon
Samsara
IOT
+$298M
3
MRNA icon
Moderna
MRNA
+$277M
4
SEDG icon
SolarEdge
SEDG
+$272M
5
POOL icon
Pool Corp
POOL
+$234M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 27.82%
2 Healthcare 22.38%
3 Technology 21.54%
4 Communication Services 11.88%
5 Financials 6.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFIB
451
DELISTED
Acutus Medical Inc
AFIB
$320 ﹤0.01%
424
AXDX
452
DELISTED
Accelerate Diagnostics
AXDX
$293 ﹤0.01%
42
EAR
453
DELISTED
Eargo, Inc. Common Stock
EAR
$61 ﹤0.01%
13
APPF icon
454
AppFolio
APPF
$7.04B
-230
Closed -$24.2K
BFLY icon
455
Butterfly Network
BFLY
$2.35B
-2,130,677
Closed -$5.24M
BMRN icon
456
BioMarin Pharmaceuticals
BMRN
$12.4B
-82
Closed -$8.49K
BRC icon
457
Brady Corp
BRC
$4.57B
-200
Closed -$9.42K
CFR icon
458
Cullen/Frost Bankers
CFR
$10.2B
-346,437
Closed -$46.3M
CLOV icon
459
Clover Health Investments
CLOV
$2.51B
-2,645,503
Closed -$2.46M
CNS icon
460
Cohen & Steers
CNS
$4.3B
-362
Closed -$23.4K
VISN
461
Vistance Networks Inc
VISN
$2.52B
-1,442
Closed -$10.6K
CRM icon
462
Salesforce
CRM
$158B
-3,312,517
Closed -$439M
CVGW
463
DELISTED
Calavo Growers
CVGW
-113
Closed -$3.32K
EBS icon
464
Emergent Biosolutions
EBS
$248M
-385
Closed -$4.55K
GKOS icon
465
Glaukos
GKOS
$10.6B
-269
Closed -$11.8K
HALO icon
466
Halozyme
HALO
$12.2B
-763
Closed -$43.4K
HUBB icon
467
Hubbell
HUBB
$27.2B
-87
Closed -$20.4K
HUBS icon
468
HubSpot
HUBS
$10.5B
-126
Closed -$36.4K
PPLI
469
People Inc
PPLI
$3.1B
-1,839,837
Closed -$67M
IE icon
470
Ivanhoe Electric
IE
$1.74B
-1,400
Closed -$11.1K
INGN icon
471
Inogen
INGN
$164M
-141
Closed -$2.78K
MTB icon
472
M&T Bank
MTB
$36.2B
-72,228
Closed -$10.5M
NTES icon
473
NetEase
NTES
$84.7B
-103,340
Closed -$7.51M
OXM icon
474
Oxford Industries
OXM
$552M
-55
Closed -$5.13K
SIMO icon
475
Silicon Motion
SIMO
$8.68B
-414,300
Closed -$26.9M

Similar funds

Baillie Gifford & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Baillie Gifford & Co held 493 positions worth $111B, up 15% from $96B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Baillie Gifford & Co's Q1 2023 filing shows 5 new, 168 increased, 169 reduced and 39 closed positions. Its largest new stake was Samsara: 18,813,062 shares worth $371M. The largest sale was Salesforce, an estimated $439M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.

  • Baillie Gifford & Co's largest Q1 2023 buy was Samsara: 18,813,062 shares worth $371M.
  • Baillie Gifford & Co added most to Advanced Micro Devices in Q1 2023, an estimated $710M increase.
  • Baillie Gifford & Co's biggest Q1 2023 reduction was Illumina, cutting an estimated $351M.
  • Baillie Gifford & Co fully exited Salesforce in Q1 2023, selling an estimated $439M.
  • Baillie Gifford & Co's ten largest holdings make up 40% of its $111B portfolio in Q1 2023.
  • Baillie Gifford & Co opened 5 new positions and closed 39 in Q1 2023.
  • Baillie Gifford & Co's portfolio value rose 15% quarter-over-quarter to $111B.

Based on Baillie Gifford & Co's 13F filing for Q1 2023, filed 3 May 2023.